Diabetes runs in your family. Your genes may be why.

TCF7L2 is a transcription factor that sits at the master control panel of your pancreas. Its job is to tell your beta cells when and how much insulin to release in response to rising blood sugar. It’s also involved in regulating glucose metabolism in the liver. When this gene works properly, your pancreas releases the right amount of insulin at the right time, keeping your blood sugar stable.

Here’s where the problem starts: the T allele variant at rs7903146 is present in roughly 30% of the population, making this the strongest common genetic risk factor for type 2 diabetes. If you carry this variant, your pancreas releases less insulin in response to glucose, and it releases it more slowly. Your cells are sending signals to your pancreas that blood sugar is rising, but the response is blunted.

What this feels like in real life: you eat a meal and your blood sugar spikes higher than it should. Your pancreas eventually catches up and releases insulin, but by then you’ve already spent an hour with elevated blood sugar. Over time, this pattern exhausts your beta cells. They work harder and harder to compensate, eventually burning out. This is the path to type 2 diabetes.

MTNR1B is the melatonin receptor in your pancreatic beta cells. It’s part of your circadian rhythm system. When it’s dark and you’re sleeping, melatonin rises and signals your beta cells to dial back insulin secretion. This is normal and healthy. Your body doesn’t need to be producing and secreting insulin while you’re asleep. But when morning comes and light hits your eyes, melatonin drops and insulin secretion ramps back up.

The G allele variant at rs10830963 is present in roughly 30% of the population. If you carry this variant, your beta cells respond too aggressively to melatonin’s signal, suppressing insulin secretion even after you’ve woken up. You might have a genetic tendency toward elevated fasting blood glucose because your cells stayed in sleep mode too long after you woke up.

What this feels like: you skip breakfast, thinking you’re being metabolically clever with intermittent fasting. But your fasting glucose is actually rising throughout the morning because your insulin secretion isn’t ramping up the way it should. By the time you eat lunch, your blood sugar is already elevated. Your meter shows a fasting glucose of 105 or 110, and you’re confused because you haven’t eaten anything.

KCNJ11 encodes an inward rectifier potassium channel that sits on the surface of your pancreatic beta cells. This channel is critical for the electrical signaling that triggers insulin release. Here’s how it normally works: when blood glucose rises, it enters the beta cell and gets metabolized, creating ATP. This ATP closes the potassium channel, causing the beta cell to depolarize and release insulin. It’s an elegant system: glucose comes in, the door closes, insulin goes out.

The K allele at rs5219 is present in roughly 35-40% of the population. If you carry this variant, the potassium channel doesn’t close as efficiently in response to ATP, making it harder for your beta cells to depolarize and release insulin. Your cells are essentially more resistant to the signal that says, ‘release insulin now.’

What this feels like: you eat carbohydrates and your blood sugar rises, but your pancreas is sluggish to respond. It’s like your cells are standing in a control room watching glucose levels climb, but they can’t push the button to release insulin fast enough. Two hours after eating, your glucose is finally coming down, but it went higher and stayed elevated longer than it should have.

SLC30A8 encodes a zinc transporter that sits on the cell membrane of pancreatic beta cells. Its job is to pump zinc into the cell where it’s used for one critical task: packaging and crystallizing insulin so it can be stored and released properly. Without adequate zinc transport, your beta cells can’t store insulin efficiently. The insulin gets synthesized but can’t be properly packaged. It’s like your factory can make the product, but can’t put it in boxes.

The W allele at rs13266634 is present in roughly 30% of the population. If you carry this variant, zinc transport into your beta cells is impaired, meaning your cells struggle to package and secrete insulin efficiently. You’re making insulin, but you’re not exporting it effectively into your bloodstream.

What this feels like: you develop what looks like insulin resistance, but it’s actually insulin secretion deficiency dressed up to look like resistance. Your bloodwork shows elevated insulin levels (your pancreas is working overtime to compensate) and elevated glucose. You’ve been told you have insulin resistance, so you cut carbs. But your real problem is that your beta cells can’t get the insulin out of the cell fast enough. Diet helps because you’re eating less glucose, but you’re not fixing the underlying zinc transport problem.

PPARG is a nuclear receptor that controls fat storage, fat cell differentiation, and insulin sensitivity. When it works optimally, it stores fat efficiently in subcutaneous tissue (under your skin) where it’s relatively metabolically neutral. But PPARG also influences how responsive your whole body is to insulin. It’s a key player in the insulin signaling pathway. Normally, eating triggers insulin release, insulin binds to receptors, and your cells take up glucose. PPARG helps make that whole system work smoothly.

The Pro12 allele is present in roughly 25% of the population. If you carry the Pro12 variant, your body stores fat very efficiently, which sounds good until you realize that efficient fat storage also means more visceral fat (fat around your organs) and impaired insulin sensitivity throughout your body. You’re biologically programmed to store fat easily and to respond less effectively to insulin signals.

What this feels like: you’ve always been a person who gains weight easily. You eat the same amount as your friends, exercise the same amount, and yet you accumulate fat more readily, especially around your midsection. Your bloodwork eventually shows elevated triglycerides and elevated glucose because the visceral fat you’re accumulating is actively interfering with insulin signaling. Standard weight loss advice doesn’t work as well because your genetics are making you very efficient at storing and holding onto fat.

IRS1 is insulin receptor substrate 1, a critical protein that sits downstream of the insulin receptor. When insulin binds to your cell’s receptor, IRS1 is the next domino that falls. It carries the signal deeper into the cell, telling it to take up glucose. If IRS1 isn’t working well, the insulin signal gets lost. Your cells receive the message, but they don’t act on it. Your pancreas releases insulin, but your muscle and fat cells aren’t listening.

The variant at rs2943641 is present in roughly 35% of the population. If you carry this variant, your cells produce less IRS1 protein, meaning the insulin signal doesn’t propagate as effectively into your cells. You develop what looks like true insulin resistance: your pancreas is releasing insulin, but your muscles and liver aren’t taking up glucose the way they should.

What this feels like: you exercise regularly and eat a reasonable diet, but your glucose stays elevated and your triglycerides are high. Your doctor says you have insulin resistance, and you’re not wrong. But the resistance isn’t because you’re overweight or sedentary; it’s because your cells aren’t responding to insulin signals at the molecular level. You could be lean and fit and still have impaired insulin signaling because of this gene.